Literature DB >> 19903783

Epidermal growth factor receptor is required for colonic tumor promotion by dietary fat in the azoxymethane/dextran sulfate sodium model: roles of transforming growth factor-{alpha} and PTGS2.

Urszula Dougherty1, Dario Cerasi, Ieva Taylor, Masha Kocherginsky, Ummuhan Tekin, Shamiram Badal, Lata Aluri, Amikar Sehdev, Sonia Cerda, Reba Mustafi, Jorge Delgado, Loren Joseph, Hongyan Zhu, John Hart, David Threadgill, Alessandro Fichera, Marc Bissonnette.   

Abstract

PURPOSE: Colon cancer is a major cause of cancer deaths. Dietary factors contribute substantially to the risk of this malignancy. Western-style diets promote development of azoxymethane-induced colon cancer. Although we showed that epidermal growth factor receptors (EGFR) controlled azoxymethane tumorigenesis in standard fat conditions, the role of EGFR in tumor promotion by high dietary fat has not been examined. EXPERIMENTAL
DESIGN: A/J x C57BL6/J mice with wild-type Egfr (Egfr(wt)) or loss-of-function waved-2 Egfr (Egfr(wa2)) received azoxymethane followed by standard (5% fat) or western-style (20% fat) diet. As F(1) mice were resistant to azoxymethane, we treated mice with azoxymethane followed by one cycle of inflammation-inducing dextran sulfate sodium to induce tumorigenesis. Mice were sacrificed 12 weeks after dextran sulfate sodium. Tumors were graded for histology and assessed for EGFR ligands and proto-oncogenes by immunostaining, Western blotting, and real-time PCR.
RESULTS: Egfr(wt) mice gained significantly more weight and had exaggerated insulin resistance compared with Egfr(wa2) mice on high-fat diet. Dietary fat promoted tumor incidence (71.2% versus 36.7%; P < 0.05) and cancer incidence (43.9% versus 16.7%; P < 0.05) only in Egfr(wt) mice. The lipid-rich diet also significantly increased tumor and cancer multiplicity only in Egfr(wt) mice. In tumors, dietary fat and Egfr(wt) upregulated transforming growth factor-alpha, amphiregulin, CTNNB1, MYC, and CCND1, whereas PTGS2 was only increased in Egfr(wt) mice and further upregulated by dietary fat. Notably, dietary fat increased transforming growth factor-alpha in normal colon.
CONCLUSIONS: EGFR is required for dietary fat-induced weight gain and tumor promotion. EGFR-dependent increases in receptor ligands and PTGS2 likely drive diet-related tumor promotion.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19903783      PMCID: PMC2785126          DOI: 10.1158/1078-0432.CCR-09-1678

Source DB:  PubMed          Journal:  Clin Cancer Res        ISSN: 1078-0432            Impact factor:   12.531


  48 in total

Review 1.  Pathology of mouse models of intestinal cancer: consensus report and recommendations.

Authors:  Gregory P Boivin; Kay Washington; Kan Yang; Jerrold M Ward; Theresa P Pretlow; Robert Russell; David G Besselsen; Virginia L Godfrey; Tom Doetschman; William F Dove; Henry C Pitot; Richard B Halberg; Steven H Itzkowitz; Joanna Groden; Robert J Coffey
Journal:  Gastroenterology       Date:  2003-03       Impact factor: 22.682

2.  Cyclooxygenase-2 expression in fibroblasts and endothelial cells of intestinal polyps.

Authors:  Masahiro Sonoshita; Kazuaki Takaku; Masanobu Oshima; Ken-ichi Sugihara; Makoto M Taketo
Journal:  Cancer Res       Date:  2002-12-01       Impact factor: 12.701

3.  Comparative genomic sequence analysis and isolation of human and mouse alternative EGFR transcripts encoding truncated receptor isoforms.

Authors:  J L Reiter; D W Threadgill; G D Eley; K E Strunk; A J Danielsen; C S Sinclair; R S Pearsall; P J Green; D Yee; A L Lampland; S Balasubramaniam; T D Crossley; T R Magnuson; C D James; N J Maihle
Journal:  Genomics       Date:  2001-01-01       Impact factor: 5.736

4.  A Western-style diet induces benign and malignant neoplasms in the colon of normal C57Bl/6 mice.

Authors:  H L Newmark; K Yang; M Lipkin; L Kopelovich; Y Liu; K Fan; H Shinozaki
Journal:  Carcinogenesis       Date:  2001-11       Impact factor: 4.944

5.  Chemoprevention of colon cancer by specific cyclooxygenase-2 inhibitor, celecoxib, administered during different stages of carcinogenesis.

Authors:  B S Reddy; Y Hirose; R Lubet; V Steele; G Kelloff; S Paulson; K Seibert; C V Rao
Journal:  Cancer Res       Date:  2000-01-15       Impact factor: 12.701

6.  Importance of epidermal growth factor receptor signaling in establishment of adenomas and maintenance of carcinomas during intestinal tumorigenesis.

Authors:  Reade B Roberts; Lu Min; M Kay Washington; Sandra J Olsen; Stephen H Settle; Robert J Coffey; David W Threadgill
Journal:  Proc Natl Acad Sci U S A       Date:  2002-01-29       Impact factor: 11.205

7.  K-Ras-mediated increase in cyclooxygenase 2 mRNA stability involves activation of the protein kinase B1.

Authors:  H Sheng; J Shao; R N Dubois
Journal:  Cancer Res       Date:  2001-03-15       Impact factor: 12.701

8.  Modulation of experimental colon tumorigenesis by types and amounts of dietary fatty acids.

Authors:  C V Rao; Y Hirose; C Indranie; B S Reddy
Journal:  Cancer Res       Date:  2001-03-01       Impact factor: 12.701

9.  Effect of bile acids and dietary fat on large bowel carcinogenesis in animal models.

Authors:  T Narisawa; B S Reddy; J H Weisburger
Journal:  Gastroenterol Jpn       Date:  1978

10.  Regulation of cyclooxygenase-2 expression by the Wnt and ras pathways.

Authors:  Yuzuru Araki; Shu Okamura; S Perwez Hussain; Makoto Nagashima; Peijun He; Masayuki Shiseki; Koh Miura; Curtis C Harris
Journal:  Cancer Res       Date:  2003-02-01       Impact factor: 12.701

View more
  20 in total

Review 1.  MicroRNA, nutrition, and cancer prevention.

Authors:  Sharon A Ross; Cindy D Davis
Journal:  Adv Nutr       Date:  2011-11-03       Impact factor: 8.701

2.  Epidermal growth factor receptor inhibits colitis-associated cancer in mice.

Authors:  Philip E Dubé; Fang Yan; Shivesh Punit; Nandini Girish; Steven J McElroy; M Kay Washington; D Brent Polk
Journal:  J Clin Invest       Date:  2012-07-09       Impact factor: 14.808

3.  EGFR signals downregulate tumor suppressors miR-143 and miR-145 in Western diet-promoted murine colon cancer: role of G1 regulators.

Authors:  Hongyan Zhu; Urszula Dougherty; Victoria Robinson; Reba Mustafi; Joel Pekow; Sonia Kupfer; Yan Chun Li; John Hart; Kathleen Goss; Alessandro Fichera; Loren Joseph; Marc Bissonnette
Journal:  Mol Cancer Res       Date:  2011-06-08       Impact factor: 5.852

Review 4.  The Role of Aspirin, Vitamin D, Exercise, Diet, Statins, and Metformin in the Prevention and Treatment of Colorectal Cancer.

Authors:  Amikar Sehdev; Bert H O'Neil
Journal:  Curr Treat Options Oncol       Date:  2015-09

5.  ADAM17 is a Tumor Promoter and Therapeutic Target in Western Diet-associated Colon Cancer.

Authors:  Reba Mustafi; Urszula Dougherty; Devkumar Mustafi; Fatma Ayaloglu-Butun; Michelle Fletcher; Sarbani Adhikari; Farhana Sadiq; Katherine Meckel; Haider I Haider; Abdurahman Khalil; Joel Pekow; Vani Konda; Loren Joseph; John Hart; Alessandro Fichera; Yan Chun Li; Marc Bissonnette
Journal:  Clin Cancer Res       Date:  2016-08-03       Impact factor: 12.531

Review 6.  Colon cancer and the epidermal growth factor receptor: Current treatment paradigms, the importance of diet, and the role of chemoprevention.

Authors:  Baldeep Pabla; Marc Bissonnette; Vani J Konda
Journal:  World J Clin Oncol       Date:  2015-10-10

7.  A novel mouse model of sporadic colon cancer induced by combination of conditional Apc genes and chemical carcinogen in the absence of Cre recombinase.

Authors:  Jeffrey S Souris; Hannah J Zhang; Urszula Dougherty; Nai-Tzu Chen; Joseph V Waller; Leu-Wei Lo; John Hart; Chin-Tu Chen; Marc Bissonnette
Journal:  Carcinogenesis       Date:  2019-11-25       Impact factor: 4.944

8.  Losartan and Vitamin D Inhibit Colonic Tumor Development in a Conditional Apc-Deleted Mouse Model of Sporadic Colon Cancer.

Authors:  Urszula Dougherty; Reba Mustafi; Haider I Haider; Abdurahman Khalil; Jeffrey S Souris; Loren Joseph; John Hart; Vani J Konda; Wei Zhang; Joel Pekow; Yan Chun Li; Marc Bissonnette
Journal:  Cancer Prev Res (Phila)       Date:  2019-05-14

9.  The renin-angiotensin system mediates EGF receptor-vitamin d receptor cross-talk in colitis-associated colon cancer.

Authors:  Urszula Dougherty; Reba Mustafi; Farhana Sadiq; Anas Almoghrabi; Devkumar Mustafi; Maggi Kreisheh; Sumana Sundaramurthy; Weicheng Liu; Vani J Konda; Joel Pekow; Sharad Khare; John Hart; Loren Joseph; Alice Wyrwicz; Gregory S Karczmar; Yan Chun Li; Marc Bissonnette
Journal:  Clin Cancer Res       Date:  2014-09-11       Impact factor: 12.531

10.  Both stromal cell and colonocyte epidermal growth factor receptors control HCT116 colon cancer cell growth in tumor xenografts.

Authors:  Reba Mustafi; Urszula Dougherty; Hardik Shah; Hooman Dehghan; Ariel Gliksberg; Jiang Wu; Hongyan Zhu; Loren Joseph; John Hart; Caroline Dive; Alessandro Fichera; David Threadgill; Marc Bissonnette
Journal:  Carcinogenesis       Date:  2012-07-12       Impact factor: 4.944

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.